Pharmaceutical Ceftriaxone Sodium for Injection 1000mg Wholesale Medicine

Ceftriaxone Sodium for Injection

Specification 1000 1ampoules/ Tray/Box

Shelf life 3years
Storage Store below 30°C.
Therapeutic indications
For lower respiratory tract infections caused by sensitive pathogens, urinary tract, biliary tract infections, as well as abdominal infections, pelvic infections, skin and soft tissue infections, bone and joint infections, sepsis, meningitis, etc. and prevention of infection during surgery. This product can treat simple gonorrhea in a single dose.
Dose and method of administration
General infection, 1g daily, 1 intramuscular injection or intravenous injection. Severe infection, 2g daily, given in 2 divided doses. Meningitis can be given in two doses of 100 mg/kg per day (but not more than 4 g in total). Gonorrhea, a single dose of 250mg is sufficient. The amount of children is generally given in 1/2 of the adult amount. Intramuscular injection: One dose is dissolved in an appropriate amount of 0.5% lidocaine hydrochloride injection for deep intramuscular injection. Intravenous injection: Dissolve 1 g of the drug in 10 ml of sterile water for injection and slowly inject for 2-4 minutes. Intravenous infusion: 1 g in an adult or 2 g in 1 day, dissolved in isotonic sodium chloride injection or 50-100 ml of 5%-10% glucose solution, and instilled within 0.5-1 hour.
Adverse reactions

Adverse reactions are related to the dose and course of treatment. Local reactions include phlebitis (1.86%), in addition to rash, itching, fever, bronchospasm and serum sickness (2.77%), headache or dizziness (0.27%), diarrhea, nausea, vomiting, abdominal pain, colitis Digestive tract reactions such as jaundice, flatulence, taste disturbance and indigestion (3.45%). Laboratory abnormalities were about 19%, with abnormal hematology accounting for 14%, including eosinophilia, thrombocytosis or reduction, and leukopenia. Patients with abnormal liver and kidney function were 5% and 1.4%.